GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $444,000 | +108.5% | 6,500 | 0.0% | 0.11% | +131.9% |
| Q2 2022 | $213,000 | -52.7% | 6,500 | -50.0% | 0.05% | -46.6% |
| Q1 2022 | $450,000 | +99.1% | 13,000 | +92.6% | 0.09% | +100.0% |
| Q2 2021 | $226,000 | -20.7% | 6,750 | 0.0% | 0.04% | -26.7% |
| Q1 2021 | $285,000 | -13.6% | 6,750 | 0.0% | 0.06% | -20.0% |
| Q4 2020 | $330,000 | -19.1% | 6,750 | 0.0% | 0.08% | -32.4% |
| Q3 2020 | $408,000 | – | 6,750 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |